Editas Medicine insider plans sale of 5,500 shares

Linda C. Burkly has notified of an intention to sell up to 5,500 shares of Common Stock of Editas Medicine on or after 07/27/2026 on NASDAQ.

Rhea-AI Filing Summary

Linda C. Burkly has notified of an intention to sell up to 5,500 shares of Common Stock of Editas Medicine on or after 07/27/2026 on NASDAQ. The planned sale relates to shares associated with Restricted Stock Unit vesting, with 11,292 shares shown as acquired from the issuer as equity compensation on 07/24/2026.

During the prior three months, Burkly sold 731 shares of Common Stock for $1,974.50 on 06/03/2026. These details outline upcoming and recent insider share transactions but do not themselves state any change in company operations or financial results.

Key Figures

Planned shares to be sold: 5,500 shares Planned aggregate market value: $15,840.00 Recent shares sold: 731 shares +3 more

6 metrics

Planned shares to be sold 5,500 shares Common Stock sale on or after 07/27/2026 on NASDAQ

Planned aggregate market value $15,840.00 Aggregate market value for the 5,500 shares of Common Stock

Recent shares sold 731 shares Common Stock sold on 06/03/2026 during the past 3 months

Proceeds from recent sale $1,974.50 Total consideration for 731 shares sold on 06/03/2026

Shares from RSU vesting 11,292 shares Common Stock acquired from issuer as equity compensation on 07/24/2026

Planned sale date 07/27/2026 Stated date for proposed sale of 5,500 shares

Key Terms

Restricted Stock Unit Vesting, Equity Compensation, Securities Sold During The Past 3 Months, Common Stock

4 terms

Restricted Stock Unit Vesting financial

"Common Stock | 07/24/2026 | Restricted Stock Unit Vesting | Issuer"

Equity Compensation financial

"11292 | 07/24/2026 | Equity Compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

Securities Sold During The Past 3 Months regulatory

"144: Securities Sold During The Past 3 Months"

Common Stock financial

"Common Stock | ETrade Corporation 3 Edison Financial Alphareta GA 30005 | 5500"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider share sale is Editas Medicine (EDIT) disclosing?

The notice indicates Linda C. Burkly plans to sell up to 5,500 shares of Common Stock of Editas Medicine on or after 07/27/2026 through transactions on NASDAQ.

What is the source of the Editas Medicine (EDIT) shares to be sold?

The Common Stock relates to Restricted Stock Unit vesting, with 11,292 shares shown as acquired from the issuer on 07/24/2026 as equity compensation.

What recent Editas Medicine (EDIT) insider sales has Linda C. Burkly made?

In the past three months, Linda C. Burkly sold 731 shares of Editas Medicine Common Stock on 06/03/2026 for total proceeds of $1,974.50, according to the transaction disclosure.

On which market will the planned Editas Medicine (EDIT) share sale occur?

The planned sale of up to 5,500 shares of Editas Medicine Common Stock by Linda C. Burkly is indicated as occurring on the NASDAQ market on or after 07/27/2026.

Does this Editas Medicine (EDIT) insider transaction involve new equity compensation?

Yes. The disclosure ties the Common Stock to Restricted Stock Unit vesting, showing 11,292 shares received from the issuer on 07/24/2026 as equity compensation before potential sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/21/2026 - 04:37 PM Accepted by SEC EDGAR 07/21/2026 - 04:37 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001985604
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Editas Medicine, Inc.
SEC File Number	001-37687
Address of Issuer	11 HURLEY ST. CAMBRIDGE MASSACHUSETTS 02141
Phone	617-401-9000
Name of Person for Whose Account the Securities are To Be Sold	Burkly Linda
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	ETrade Corporation 3 Edison Financial Alphareta GA 30005	5500	15840.00	153461838	07/27/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	07/24/2026	Restricted Stock Unit Vesting	Issuer			11292	07/24/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Linda C. Burkly 11 Hurley Street Cambridge MA 02141	Common Stock	06/03/2026	731	1974.50

144: Remarks and Signature

Remarks
Date of Notice	07/21/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	07/03/2023
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Linda C. Burkly
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)